Hospital Universitario Central de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2024

  1. Management of cerebral venous thrombosis in Spain: MOTIVATE descriptive study

    Neurologia, Vol. 39, Núm. 3, pp. 226-234

2021

  1. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  2. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

  3. Time Trends in Intracerebral Hemorrhage Associated with Oral Anticoagulation and Its Risks Factors in Spain from 2008 to 2015

    European Neurology, Vol. 84, Núm. 1, pp. 16-21

2019

  1. The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study

    European Journal of Neurology, Vol. 26, Núm. 2, pp. 230-237

2018

  1. Prognostic factors and analysis of mortality due to brain haemorrhages associated with vitamin K antagonist oral anticoagulants. Results from the TAC registry

    Neurologia, Vol. 33, Núm. 7, pp. 419-426

2015

  1. Early embryonic and endometrial regulation of tumor necrosis factor and tumor necrosis factor receptor 2 in the cattle uterus

    Theriogenology, Vol. 83, Núm. 6, pp. 1028-1037

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Estudio experimental sobre los efectos de la quercetina en la disfunción orgánica y cognitiva originada por radiación ionizante

    Trauma (Spain), Vol. 24, Núm. 1, pp. 24-32

2006

  1. Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial

    Cerebrovascular Diseases, Vol. 22, Núm. 2-3, pp. 162-169